Paramount secures final required clearance, but $110 billion Warner Bros. deal remains on hold
Paramount Skydance said it obtained the last regulatory clearance needed for its acquisition of Warner Bros. Discovery, valuing the deal at $110 billion enterprise value and $81 billion equity. However, US antitrust litigation keeps the parties from closing or integrating. Paramount pays $31 per WBD share and a daily “ticking fee” after Sept. 30, capped at $0.25 per share.
How this was made
The 30-second read
Why it matters
The article distinguishes between obtaining all regulatory clearances and being legally permitted to close, with a federal court order remaining the gating factor. It also quantifies deal economics via the cash-per-share price, the ticking fee mechanics, and the termination/extension timetable.
Market read
Traders should update deal probability: regulatory clearance is no longer the bottleneck, but the injunction and trial schedule keep timing and expected value uncertain.
What to watch
The ticking fee is payable only upon closing, so prolonged litigation can still shift expected value materially even if regulatory risk is reduced.
Background
Paramount Skydance is acquiring Warner Bros. Discovery in a $110B enterprise-value transaction, with US antitrust litigation by state AGs and a parallel Writers Guild case delaying closing.
Ticker impact
Warner Bros. Discovery remains unable to close the $110B Paramount acquisition despite final regulatory clearances, with the court order extending the hold.
Stock may trade with deal-probability swings, balancing reduced regulatory risk against prolonged legal uncertainty.
The article specifies the court order prevents closing/integration until the earlier of post-merits timing or June 1, 2027, and that the daily ticking fee begins accumulating after Sept 30 if the deal has not closed.
Market effects
Prolonged uncertainty around major studio and cable consolidation could keep leverage and content-investment decisions cautious across media.
US antitrust litigation timing remains the binding constraint despite approvals in multiple jurisdictions.
Non-US clearances do not resolve the US court’s market-definition and competition findings, keeping global deal timelines uncertain.
Counterpoint
Final regulatory clearance could increase odds of a negotiated settlement with states, potentially compressing the injunction timeline versus a worst-case trial outcome.
Key entities
- companyParamount Skydance
Says it obtained every regulatory clearance required for the WBD acquisition, but closing is still barred by a federal court order.
- companyWarner Bros. Discovery
Remains legally barred from closing the merger despite final regulatory clearances, with deal economics including a ticking fee after Sept 30.
- legalState attorneys general coalition
Sued to block the deal under the Clayton Act, leading to a temporary restraining order and a court-approved no-close agreement.
- legalWriters Guild of America West and East
Brought a parallel antitrust case covered by the same court order, with trial scheduled for March 2 to March 19, 2027.
- legalUS District Court for the Northern District of California
Issued the restraining order and sets the timetable that prevents closing and integration until specified dates.
